Renal Transplant Donor of Left Kidney Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, 9-month, Parallel Group Study of Allopurinol to Reduce Left Ventricular Mass in Living Kidney Donors (AL-DON)
Recently there was described an increase in left ventricular mass after kidney donation. It is uncertain whether this is reversible or not. Allopurinol lowers uric acid in the blood and is normally indicated for gout, but studies have showed that it also can reduce the thickness of the left ventricle of the heart in people with heart- and kidney disease. The investigators wish to give allopurinol or placebo to kidney donors based on randomization and investigate if this has the same effect on kidney donors. The investigators are assessing this by performing a cardiac MRI at baseline and after 9 months of treatment. In addition the investigators wish to see if allopurinol can have beneficial effects on blood pressure and insulin sensitivity as well.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06197620 -
Effectiveness of Thread Embedding Acupuncture Analgesia at the EX-B2 Point Combined With Standard Therapy After Laparoscopic Living Donor Nephrectomy
|
N/A | |
| Completed |
NCT02838134 -
Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery
|
Phase 4 | |
| Active, not recruiting |
NCT02811835 -
TransplantLines Food and Nutrition Biobank and Cohort Study (TxL-FN)
|
N/A | |
| Completed |
NCT03520205 -
Quadratus Lumborum Block Versus Epidural for Laparoscopic Nephrectomy Kidney Donor
|
N/A | |
| Completed |
NCT04810884 -
Fractures and Bone Disease in Living Kidney Donors
|
||
| Completed |
NCT01925677 -
Robotic Single Port Donor Nephrectomy
|
N/A | |
| Completed |
NCT02699489 -
Enhanced Recovery Open Versus Laparoscopic Donor Nephrectomy
|
Phase 3 |